News
5h
Stocktwits on MSNGlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s WhyRetail chatter spiked last week as investors piled into three healthcare stocks: GlucoTrack, Sarepta Therapeutics, and TNF ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
11h
MyChesCo on MSNFDA Approves Gardenia Blue as Natural Dye in Major Move to Eliminate Synthetic Food ColorsThe U.S. Food and Drug Administration (FDA) has approved the use of gardenia (genipin) blue as a color additive in a range of food products, marking the fourth ...
The FDA is targeting ultraprocessed foods for reform to improve healthfulness of children's food. Whether the approach is comprehensive remains to be seen.
17h
The Western Journal on MSNGood News for Ice Cream Lovers: Key Manufacturers Make Big Health Vow Targeting 2028Robert F. Kennedy Jr.'s strategy as head of the Department of Health and Human Services is bearing fruit with regard to ice cream as various federal agencies announce that International Dairy Foods ...
Food and Drug Administration Commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss the MAHA push as major ...
When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...
1d
Health and Me on MSN"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling RulesThe FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as ...
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.
(NEXSTAR) — Dozens of companies that make ice cream and frozen dairy desserts announced on Monday that they would remove artificial food dyes from their products by 2028, marking yet another voluntary ...
Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results